Form D Explorer
Aer Therapeutics, Inc. · CIK 1959576

Report a data issueCitable research briefCompare issuerPrivate research collection

Aer Therapeutics, Inc.

CIK 1959576 · Corporation · Inc. DELAWARE · Research Triangle Park, North Carolina · Biotechnology
Sign up to follow Sign in for contact lookup
Filings
2
Original notices
2
Amendments
0
Activity
Feb 7, 2025
through Aug 19, 2026

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Differences between reported disclosures

Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.

Unavailable values are shown as a dash; reported zero remains zero.
FieldFeb 7, 2025 · DAug 19, 2026 · DLater minus earlier
Reported offering amount$5,000,000$3,000,000$-2,000,000
Reported amount sold$5,000,000$3,000,000$-2,000,000
Reported investor count—7—
Reported minimum investment$0$0$0

Earlier SEC source: 0001998609-25-000004 · Later SEC source: 0001959576-26-000001

Choose filings to compare · Research this issuer step by step

Latest available filing snapshot

Form D · Aug 19, 2026

Reported offering amount
$3,000,000
Reported exemptions
Rule 506(b)
Reported amount sold
$3,000,000

This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.

Filings by year

Submission counts, including amendments; not dollars raised or distinct funding rounds.

Form D filings (2)